Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
March 1, 2024BMJOpen Access

1ISG-001 Analysis of the use of oral oncology targeted therapies in a region of Spain

View Full Paper
Ask AI
Bookmark
Share

Authors

CECristian Rosas EspinozaVCV Alonso CastroEGEstrella Maroto García

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Espinoza et al. (2024) studied this question.

synapsesocial.com/papers/68e7692cb6db6435876df1cfhttps://doi.org/10.1136/ejhpharm-2024-eahp.13
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Factors influencing the reimbursement decisions of cancer drugs in Spanish National Health System2026
  2. 2Real-World Prevalence, Treatment Patterns, and Economic Impact of EGFR- and ALK-Targeted Therapies in Non-Small Cell Lung Cancer: A Nationwide Analysis from Greece2025
  3. 34CPS-068 Target therapy in non-small cell lung cancer (NSCLC): a retrospective analysis to guarantee the appropriateness of the prescriptions in our hospital2024 · 1 citations
  4. 42SPD-002 Evaluation of the effectiveness and related cost of oncology drugs used in special situations, in a third-level university hospital2024
  5. 5Challenges in the measurement and valuation of oncological treatments in Spain: recommendations and call to action2026